23andMe to delist from Nasdaq, deregister with SEC

cnbc.com/2025/05/27/23andme-delist-nasdaq.html

23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange Commission, according to a release.
The move comes after Regeneron Pharmaceuticals said earlier this month that it will acquire "substantially all" of 23andMe's…

This story appeared on cnbc.com, 2025-05-27 19:03:14.
The Entire Business World on a Single Page. Free to Use →